A phase II trial of oxaliplatin, docetaxel, and bevacizumab as first-line therapy of advanced cancer of the ovary, peritoneum, and fallopian tube.

Herzog, T. J.,Monk, B. J.,Rose, P. G.,Braly, P.,Hines, J. F.,Bell, M. C.,Wenham, R. M.,Secord, A. A.,Roman, L. D.,Einstein, M. H.,Drake, R. D.,Childs, B. H.; Gynecol. Oncol.. 2014 Jan 31.

Mural nodules of clear cell carcinoma in a mucinous borderline tumor of the ovary: a case report

Allende, D. S., Drake, R. D., Chen, L.; Patholog Res Int. 2010.

A phase II evaluation of pemetrexed (Alimta, LY231514, IND #40061) in the treatment of recurrent or persistent endometrial carcinoma: a phase II study of the Gynecolog...

Miller, D.S., Blessing, J.A., Drake, R.D., Higgins, R., McMeekin, D.S., Puneky, L.V., Krasner, C.N.; Gynecol Oncol. 2009-12-01.